We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Editorial: Prognostic Research and Precision Oncology in Upper Tract Urothelial Carcinoma.
- Authors
Sheu, Zai-Lin; Singla, Nirmish; Chen, Chung-Hsin; Hsieh, Jer-Tsong; Yeh, Hsin-Chih
- Abstract
Keywords: upper tract urothelial carcinoma; precision oncology; symptomatic hydronephrosis; hematuria; pyruvate dehydrogenase kinase-3; acidic urine; pathology review; 7-(deoxyadenosin-N6-yl) aristolactam I EN upper tract urothelial carcinoma precision oncology symptomatic hydronephrosis hematuria pyruvate dehydrogenase kinase-3 acidic urine pathology review 7-(deoxyadenosin-N6-yl) aristolactam I 1 2 2 06/23/22 20220621 NES 220621 Upper tract urinary carcinoma (UTUC) is a rare but aggressive cancer, often leading to poor disease outcomes despite clinical interventions. Upper tract urothelial carcinoma, hematuria, 7-(deoxyadenosin-N6-yl) aristolactam I, precision oncology, symptomatic hydronephrosis, pyruvate dehydrogenase kinase-3, acidic urine, pathology review The most common and initial symptoms that UTUC patients exhibit are macro/micro hematuria and flank pain, the latter of which often arises from tumor obstruction in the urinary tract causing hydronephrosis.
- Subjects
TRANSITIONAL cell carcinoma; HYDRONEPHROSIS; ONCOLOGY; PROGNOSIS; AUTOMOBILE seats
- Publication
Frontiers in Oncology, 2022, Vol 12, p1
- ISSN
2234-943X
- Publication type
Article
- DOI
10.3389/fonc.2022.956352